As part of the Hyderabad Pharma City, Government of Telangana had launched a skilling program with the objective to train youth in and around villages to facilitate employment on 9th of August 2021. The first batch of programme consisting of 125 students was successfully concluded today The students were trained on ‘Lab Technician Cum Assistant’ and ‘Production / Manufacturing
HONOR anuncia el lanzamiento mundial de la serie HONOR Magic3 prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
‘Export of the drug has been prohibited and it is also being imported from Egypt’
The Centre on Monday told the Madras High Court that seven Indian licensees of patented anti-viral drug Remdesivir were manufacturing only 27 lakh vials a month as on April 1 this year, though their installed capacity was 38.80 lakh a month. Now, due to the surge in COVID-19 cases in certain parts of the country, the Drugs Controller General of India (DCGI) has permitted them to produce as many as 1.19 crore vials a month.
Appearing before the first Division Bench of Chief Justice Sanjib Banerjee and Justice Senthilkumar Ramamoorthy, Additional Solicitor General (ASG) R. Sankaranarayanan said the patent for Remdesivir was held by Gilead of the United States and only seven Indian companies were manufacturing the drug here, under license agreements. DCGI V.G. Somani jumped into action when the demand for the drug increased recently.
Covid-19 | Remdesivir production stepped up, Centre tell Madras High Court thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.